Newly Published Data Continue to Support Long-Term Efficacy of TEPEZZA® (teprotumumab-trbw) for Thyroid Eye Disease (TED)
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics announced data supporting the long-term efficacy of TEPEZZA (teprotumumab-trbw) for the treatment of Thyroid Eye Disease (TED).